Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Micafungin in Neonates with Systemic Candidiasis
NCT03421002Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- May 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of micafungin in systemic candidiasis, Candida meningitis, sponsored by Astellas Pharma. Started May 2015; status: completed.
02
Drugs
micafungin
03
Conditions
systemic candidiasisCandida meningitis
Beyond the preview
Go deeper on NCT03421002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421002.